CHD3

CHD3 CUTANA™ CUT&RUN Antibody

$445.00
SKU: 13-2009
Pack size: 100 µL
  • Type:  Polyclonal
  • Host:  Rabbit
  • Applications: CUT&RUN, IP, IHC
  • Reactivity:  Human, Mouse
  • Format:  Antigen affinity-purified
  • Target Size:  227 kDa

Description

This antibody meets EpiCypher’s "CUTANA Compatible" criteria for performance in Cleavage Under Targets and Release Using Nuclease (CUT&RUN) and/or Cleavage Under Targets and Tagmentation (CUT&Tag) approaches to genomic mapping. Every lot of a CUTANA Compatible antibody is tested in the indicated approach using EpiCypher optimized protocols and determined to yield peaks that show a genomic distribution pattern consistent with reported function(s) of the target protein. CHD3 is an understudied member of the nucleosome remodeling and deacetylase (NuRD) complex. CHD3 antibody produces CUT&RUN peaks above background (Figure 1) within gene promoters, intergenic regions, and introns (Figures 1-2).

Validation Data

CUT&RUN was performed on 500k K562 cells with 0.5 µg of either CHD3, H3K4me3 positive control (EpiCypher 13-0041), or IgG negative control (EpiCypher 13-0042) antibodies using the CUTANA™ ChIC/CUT&RUN Kit v2.0 (EpiCypher 14-1048). Library preparation was performed with 5 ng of DNA (or the total amount recovered if less than 5 ng) using the CUTANA™ CUT&RUN Library Prep Kit (EpiCypher 14-1001/14-1002). Both kit protocols were adapted for high throughput Tecan liquid handling. Libraries were run on an Illumina NextSeq2000 with paired-end sequencing (2x50 bp). Sample sequencing depth was 2.4 million reads (IgG), 4.1 million reads (H3K4me3), and 5.0 million reads (CHD3). Data were aligned to the hg19 genome using Bowtie2. Data were filtered to remove duplicates, multi-aligned reads, and blacklist regions.

Figure 1: CHD3 peaks in CUT&RUN
CUT&RUN was performed as described above. Peaks were called with MACS2. (A) Heatmaps show CHD3 peaks relative to IgG negative control antibody in aligned rows ranked by intensity (top to bottom) and colored such that red indicates high localized enrichment and blue denotes background signal. (B) The number of peaks that fall into distinct classes of functionally annotated genomic regions are shown.

Figure 2: CHD3 CUT&RUN representative browser tracks
CUT&RUN was performed as described above. Gene browser shots were generated using the Integrative Genomics Viewer (IGV, Broad Institute). Two gene loci showing CHD3 peaks at a gene promoter (top) and an intronic region (bottom) are representative of the functional annotation analysis of CHD3 peak localization in CUT&RUN (Figure 1).

Figure 3: Immunoprecipitation data
EpiCypher CHD3 antibody (3 µg) was used to immunoprecipitate whole cell lysates isolated from HeLa cells using NETN lysis buffer (1.0 mg per IP). A negative control IgG antibody and positive control antibody to a different CHD3 epitope (Bethyl Laboratories) were also used to demonstrate specificity of the IP. Immunoprecipitates were loaded onto a 4-8% SDS-PAGE gel (20% of IP loaded) and probed via western blot with Bethyl A301-219A antibody (1.0 µg/mL).

Figure 4: Immunohistochemistry data
FFPE section of human Ewing sarcoma (left) and mouse renal cell carcinoma (right) using CHD3 antibody at a dilution of 1:1,000.

Technical Information

Immunogen
Between amino acids 1950 and 2000
Storage
Stable for 1 year at 4°C from date of receipt
Formulation
Antigen affinity-purified antibody in Tris-citrate/phosphate buffer pH 7-8, 0.09% sodium azide

Recommended Dilution

CUT&RUN:
0.5 µg per reaction
Immunoprecipitation (IP):
2 - 5 µg/mg lysate
Immunohistochemistry (IHC):
1:500 - 1:2,000. Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections

Gene & Protein Information

UniProt ID
Q12873
Gene Name
CHD3
Protein Name
Chromodomain-helicase-DNA-binding protein 3
Target Size
227 kDa
Alternate Names
ATP-dependent helicase CHD3, Mi-2 autoantigen 240 kDa protein, Mi2-alpha, Zinc finger helicase (hZFH), CHD-3

Documents & Resources

Additional Info

This product is provided for commercial sale under license from Bethyl Laboratories, Inc.

Current stock: 0